← All organizations

Guangzhou FineImmune Biotechnology Co., LTD.

Government

Also known as: Guangzhou FineImmune Biotechnology Co., LTD.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

May 22, 2025

Timeline

No events for the selected filters.

Drugs by trial phase (6 distinct, 4 trials)

Phase 1 (6 own, 0 via acquisition)

Indications

Studied for

Neoplasms

Recent trials (5)

NCT06942143Lead sponsorPhase 1May 22, 2025
NCT06716619Lead sponsorPhase 1Dec 20, 2024
NCT06302062Lead sponsorPhase 1Jun 6, 2023
NCT03891706Lead sponsorPhase 1Jan 8, 2019
NCT03891706Study directorPhase 1Jan 8, 2019

Details

Last known activity: May 22, 2025